AMGEN TO BUY PRIVATELY HELD AVIDIA

Biotechnology company Amgen Inc. said Friday it will buy privately held Avidia for $290 million in cash and additional milestone payments. Business Week (http://www.businessweek.com/ap/financialnews/D8KEII700.htm)